Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized Mesenchymal Stem Cell-Derived Exosomes for Radiation-Induced Oral Mucositis
NCT07312656Phase 2Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jan 2026
- Primary completion
- Jun 2027
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 2, randomised trial of mesenchymal stem cell exosomes in oral mucositis (OM) (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Incidence of Grade >=3 Radiation-Induced Oral Mucositis at 90 days. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
mesenchymal stem cell exosomes
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT07312656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07312656.